Article
Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma.
Molecular carcinogenesis - 1 Feb 2011
Sousa Hugo, Pando Mafalda, Breda Eduardo, Catarino Raquel, Medeiros Rui
Abstract excerpt
Recent studies refer that amplification/overexpression of the principal negative regulator of p53 (Mdm2) is frequently found in several malignancies. Several studies have associated a polymorphism (SNP309 T/G) in the promoter region of MDM2 with higher levels of this protein, which will favor p53...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
